1 June 2026
Swissmedic: Changes to the Project Orbis guidance document
Swissmedic has revised the Project Orbis guidance document. In particular, the process for applications for the Project Orbis procedure is described in greater detail. The structure of the guidance document has also been modified as part of updating, and editorial changes have been made in various sections to improve clarity. The modifications that have been made do not constitute changes to the requirements for applications for the Project Orbis procedure.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting